News PainReform Ltd.

Equities

PRFX

IL0011651580

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-15 pm EDT			5-day change	1st Jan Change
0.8001 ^USD	-6.31%		+0.01%	-70.91%

Apr. 16	PainReform Prices $4 Million Offering; Shares Tumble Pre-Bell	MT
Apr. 09	Painreform Ltd. Announces Groundbreaking Results from New Studies Demonstrating the Superior In-Vitro Release Rates of PRF-110	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PAINREFORM : CONDENSED FINANCIAL STATEMENTS - Form 6-K	04:46pm	PU
PainReform Provides Business Update for the First Quarter of 2024	04:06pm	AQ
PainReform : CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com	May. 08	PU
PainReform Announces Closing of $4 Million Public Offering	Apr. 18	AQ
PainReform Prices $4 Million Offering; Shares Tumble Pre-Bell	Apr. 16	MT
PainReform Announces Pricing of $4 Million Public Offering	Apr. 16	AQ
PainReform : CEO IlanHadar Interviewed on “The Big Biz Show”	Apr. 14	PU
Painreform Ltd. Announces Groundbreaking Results from New Studies Demonstrating the Superior In-Vitro Release Rates of PRF-110	Apr. 09	CI
PainReform : Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions	Apr. 09	PU
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy	Apr. 02	AQ
PainReform Ltd. Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy	Apr. 02	CI
PainReform : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	Mar. 07	PU
PainReform : Investors Presentation – March 2024	Mar. 03	PU
PainReform Provides Year-End Business Update	Mar. 01	AQ
PainReform Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
PainReform to Present at the Microcap Conference in Atlantic City	Jan. 22	NE
PainReform to Present at the Microcap Conference in Atlantic City	Jan. 22	AQ
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief	Jan. 03	AQ
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief	Jan. 03	CI
PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds	Dec. 26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PainReform Ltd.

Equities

PRFX

IL0011651580

Summary

Filters